WHO announces clinical trial to study 3 anti-malarial drugs as potential treatment against COVID-19
The trial involves thousands of researchers in over 600 hospitals in 52 countries.
Aug 13, 2021, 19:17 PM IST
Novartis to buy US gene therapy group AveXis for $8.7 billion
It said the all-cash deal was approved unanimously by the boards of both firms.
Apr 09, 2018, 12:17 PM IST
GSK buys Novartis stake in consumer healthcare venture for $13 billion
The deal is set to complete in the second quarter subject to the necessary approvals.
Mar 27, 2018, 14:37 PM IST
US approves first gene therapy for cancer
Gene therapy is a treatment that uses a patient`s own immune cells to fight leukemia.
Aug 30, 2017, 22:50 PM IST
Sun Pharma to acquire oncology product from Novartis for $175 million
Drug major Sun Pharmaceutical Industries on Thursday said it it will acquire a branded oncology product, Odomzo, from Novartis for an upfront payment of USD 175 million.
Dec 22, 2016, 11:21 AM IST
Sniff your way to `slimmer` you with `love hormone` spray
Results in 10 overweight and obese men suggest that one way oxytocin lowers food intake might be by improving self-control, said co-investigator Franziska Plessow of the Massachusetts General Hospital, Boston.
Apr 03, 2016, 11:13 AM IST
NeoBiocon to sell anti-diabetic drug in UAE
Vildagliptin is available as monotherapy and in combination with metformin. Both the drugs commands over 30 percent of the DPP-IV market in the UAE.
Dec 10, 2015, 20:47 PM IST
Antim Baazi: NeoBiocon Partners with Novartis
NeoBiocon Partners with Novartis which shows good momentum in Biocon intra-day trading.
Dec 09, 2015, 19:38 PM IST
US fines Novartis $390 million over pharmacy kickbacks
Novartis admitted that it gave specialty pharmacies exceptional rebates and patient referrals in exchange for recommending Exjade.
Nov 21, 2015, 05:01 AM IST
Novartis India gets FIPB nod to sell OTC biz to GSK CPL
The Foreign Investment Promotion Board (FIPB) has approved the proposal made by GSK CPL to acquire the company's OTC division, Novartis India said in a BSE filing.
Aug 28, 2015, 19:32 PM IST
New-look GSK bets on consumer health spending
GSK predicted on Wednesday its consumer health sales would grow at a mid-single-digit compound annual rate over the next five years, slightly ahead of overall company sales.
May 06, 2015, 17:06 PM IST
Novartis warns of currency drag on 2015 earnings
Swiss drugmaker Novartis on Thursday posted declining sales in the first quarter and cautioned that dollar strength may be a bigger-than-expected drag on full-year figures.
Apr 23, 2015, 13:02 PM IST
GSK Pharma to transfer cancer drug portfolio to Novartis arm
GlaxoSmithKline Pharmaceuticals board on Thursday approved transfer of its cancer drugs portfolio to an arm of Novartis in India in return for acquiring vaccines portfolio as part of a global deal between the two-multinational pharma giants struck last year.
Feb 12, 2015, 21:59 PM IST
Novartis Q3 net loss at Rs 1.18 crore
Drug firm Novartis India Ltd on Wednesday reported a net loss of Rs 1.18 crore for the third quarter ended December 31, 2014.
Feb 04, 2015, 20:43 PM IST
EU puts conditions on deals involving Novartis, GSK
The European Union on Wednesday approved mega deals involving drugmakers Novartis of Switzerland and GlaxoSmithKline of Britain, provided they sell off assets in the vaccines and consumer health businesses.
Jan 29, 2015, 00:14 AM IST
Novartis profits jump 12% on new drug sales
Swiss pharmaceuticals giant Novartis said Tuesday strong sales of new products helped push its net profit up 12 percent last year despite harsh competition from cheaper copycat generic drugs.
Jan 27, 2015, 16:17 PM IST
HC order 'disappointing', says Cipla
Drug maker Cipla Friday expressed disappointment over the Delhi High Court order that restrained the company from manufacturing and selling any medicine containing 'Indacaterol', saying that the interim verdict would deny patients access to drugs they need.
Jan 09, 2015, 23:10 PM IST
Novartis shares up nearly 2% at close
Surrendering most of early gains in-line with a weak stock market, shares of Novartis India ended nearly 2 percent higher Wednesday, a day after fair trade regulator CCI approved a multi-billion dollar deal between global pharma giants GlaxoSmithKline Plc and Novartis.
Dec 24, 2014, 13:59 PM IST
CCI clears multi-billion Novartis-GSK pharma deal
Fair trade regulator CCI has approved a multi-billion dollar deal between global pharma giants GlaxoSmithKline Plc and Novartis, as it did not find the transaction to be anti-competitive ion India.
Dec 23, 2014, 20:07 PM IST
HC reserves order on Novartis-Cipla drug dispute
The Delhi High Court has reserved its verdict on a dispute between pharma firms Novartis and Cipla over manufacturing of the drug Indacaterol, used for treatment of chronic obstructive pulmonary disease.
Dec 17, 2014, 21:32 PM IST
